Results 141 to 150 of about 23,332 (236)

Novel six-month all oral treatment of pre-extensively drug-resistant tuberculosis in Canada: New treatment options present new implementation challenges. [PDF]

Can Commun Dis Rep, 2023
Connors W, Nishi C, Sekirov I, Cook V, Johnston J.   +4 more
europepmc   +1 more source

CLINICO–Demographic Profile and Outcomes of Hospitalised Children With Diphtheria in A Tertiary Care Hospital of Peshawar

Acta Paediatrica, Volume 115, Issue 8, Page 1646-1653, August 2026.
ABSTRACT Aim To determine the clinico‐demographic profile and predictors of mortality in hospitalised children with diphtheria. Methods This retrospective cohort study included 202 children aged 5–16 years diagnosed with diphtheria per WHO criteria at Lady Reading Hospital, Peshawar, from January 2023 to December 2024. Data on demographics, vaccination
Amir Muhammad, Ashfaq Ahmed, Waqas Naseem, Ale Azad Othman, Mohsin Hassan, Lyaba Atta, Muhammad Tahir   +6 more
wiley   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

Evaluation of TBMDR® and XDRA® for the detection of multidrug resistant and pre-extensively drug resistant tuberculosis. [PDF]

J Clin Tuberc Other Mycobact Dis, 2022
Cho E, Lee SJ, Lim J, Kim DS, Kim N, Park HO, Lee JI, Son E, Cho SN, Aung WW, Seok Lee J.   +10 more
europepmc   +1 more source

Genetic Landscape of NAT2 in the Moroccan Population: Implications for Isoniazid Pharmacogenetics in Tuberculosis

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT The NAT2 gene encodes N‐acetyltransferase 2, an enzyme critically involved in the biotransformation of numerous xenobiotics and aromatic amines, including isoniazid, a cornerstone drug in tuberculosis therapy. Genetic polymorphisms in NAT2 lead to variable acetylation rates, clinically categorized as poor, intermediate, or rapid metabolizer ...
Nada Benyahya, Mohsine‐Ali El‐Hamri, Jaber Lyahyai, Ilham Ratbi, Imane Cherkaoui, Zineb Rchiad, Abdelaziz Sefiani   +6 more
wiley   +1 more source

Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype. [PDF]

ERJ Open Res
Londt R, Semple L, Pooran A, Esmail A, Davids M, Dheda K, Tomasicchio M.   +6 more
europepmc   +1 more source

Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis. [PDF]

New Microbes New Infect, 2021
Keikha M, Majidzadeh M.
europepmc   +1 more source

Synthetic Ligands of Myeloid C‐Type Lectin Receptors

ChemBioChem, Volume 27, Issue 13, 14 July 2026.
Binding of ligands to C‐type lectin receptors (CLRs) on myeloid cells can lead to an array of cellular responses. Exploitation of these receptors for therapeutic purposes requires high‐affinity ligands. This review surveys the diversity of synthetic ligands of myeloid CLRs in the context of binding, signaling, and downstream effects, as well as ...
James Suri, Bernd Lepenies
wiley   +1 more source

Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant. [PDF]

Afr J Thorac Crit Care Med
Singh V, Perumal R, Wessels M, Hai F, Lutchminarain K, Naidoo K, Swe Swe-Han K.   +6 more
europepmc   +1 more source

Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis. [PDF]

J Clin Tuberc Other Mycobact Dis, 2021
Getachew E, Adebeta T, Gebrie D, Charlie L, Said B, Assefa DG, Wanjiru CL, Zeleke ED, Tesfahunei HA, Abebe M, Joseph M, Manyazewal T.   +11 more
europepmc   +1 more source